Weight-loss drugs: Can Ozempic and other drugs change the landscape of India's wellness industry?
Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...
Unlocking India’s pharma potential: Why India needs to join a 56-member global regulators association
Despite the glorious performance of the pharmaceutical sector, India faced a huge setback because of the recent incident when ...
centerforbiosimilars2d
BioRationality: What’s Wrong With the Indian CDSCO Biosimilar Guidelines?
The phase 3 trial showed biosimilar CT-P42 (Celltrion) is therapeutically equivalent to reference aflibercept in improving ...
money.rediff2d
AI-Powered Pulse Diagnostic Tool for Ayurveda: Atreya Innovations
Pune-based startup Atreya Innovations has developed an AI-powered pulse diagnostic tool for Ayurveda practitioners, 'Nadi ...
ThePrint2d
Pune-based startup develops AI-based pulse diagnostic tool for Ayurveda practitioners
Pune-based startup Atreya Innovations said it has developed an AI-based pulse diagnostic tool for Ayurveda practitioners that can monitor patients’ health on 22 parameters and generate report in 10 ...
Nadi Tarangani to standardise ayurvedic practices: JB Joshi
Pune: Nadi Tarangini, the country's first ayurvedic diagnostic tool to receive approval from Central Drugs Standard Control Organization (CDSCO), is e.
Parliamentary panel to review apex drug regulator’s performance on stopping spurious drugs
In 2023-24, around 2,988 drug samples were declared ‘not of standard quality’ while 282 drug samples were found to be ...
Nadi Tarangini, first ayurvedic diagnostic device, gets CDSCO nod
Nadi Tarangini, an indigenously developed pulse diagnostic tool, has become India’s first ayurvedic medical device to receive ...